[Correlation of the DNCB skin test and CEA assay in the prognosis of malignant neoplasms].
130 neoplastic patients were subjected to DNCB skin tests and radioimmunological CEA measurements during antiblastic and/or radiation treatment. The prognostic reliability of the two techniques was examined as was the connection between DNCB response and CEA plasma levels. Results obtained confirm the link between development of the neoplasia and immunological factors in the host organism in 73% of the cases. The connection between CEA measurement and DNCB test was noted in only 56%. Finally CEA measurements of haematic levels alone corresponded to the clinical development of the condition in 71% of the cases examined.
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D004137:Dinitrochlorobenzene; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology*; D009578:Nitrobenzenes; D011379:Prognosis; D011863:Radioimmunoassay; D012882:Skin Tests
D002272:Carcinoembryonic Antigen; D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes
Correlazione fra test cutaneo con DNCB e dosaggio del CEA nella prognosi delle neoplasie maligne.